Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $79000.0.

  • Apyx Medical's Change in Accured Expenses rose 11153.28% to $79000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$256000.0, marking a year-over-year increase of 7235.42%. This contributed to the annual value of -$2.3 million for FY2024, which is 92137.68% down from last year.
  • Latest data reveals that Apyx Medical reported Change in Accured Expenses of $79000.0 as of Q3 2025, which was up 11153.28% from $433000.0 recorded in Q2 2025.
  • Apyx Medical's Change in Accured Expenses' 5-year high stood at $1.8 million during Q4 2021, with a 5-year trough of -$1.6 million in Q1 2024.
  • For the 5-year period, Apyx Medical's Change in Accured Expenses averaged around -$7736.8, with its median value being $79000.0 (2025).
  • Per our database at Business Quant, Apyx Medical's Change in Accured Expenses surged by 104684.68% in 2021 and then tumbled by 584166.67% in 2022.
  • Over the past 5 years, Apyx Medical's Change in Accured Expenses (Quarter) stood at $1.8 million in 2021, then plummeted by 81.69% to $328000.0 in 2022, then skyrocketed by 335.67% to $1.4 million in 2023, then crashed by 93.84% to $88000.0 in 2024, then fell by 10.23% to $79000.0 in 2025.
  • Its last three reported values are $79000.0 in Q3 2025, $433000.0 for Q2 2025, and -$856000.0 during Q1 2025.